Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery

Joint Authors

Ziadinov, Edem
al-Tubi, Malik
Siddiqi, Muhammad Salman
al-Sabti, Hilal

Source

Oman Medical Journal

Issue

Vol. 29, Issue 4 (31 Aug. 2014), pp.294-295, 2 p.

Publisher

Oman Medical Specialty Board

Publication Date

2014-08-31

Country of Publication

Oman

No. of Pages

2

Main Subjects

Medicine

Abstract EN

The risk of thrombosis is high in patients with essential thrombocythemia.

Special precaution needed for those patients who will undergo Coronary artery bypass grafting.

We are reporting a 62 years old patient with ischemic heart disease who was found to have essential thrombocythemia.

This report explains the preoperative management and the postoperative risks anticipated due to the treatment

American Psychological Association (APA)

Ziadinov, Edem& al-Sabti, Hilal& al-Tubi, Malik& Siddiqi, Muhammad Salman. 2014. Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery. Oman Medical Journal،Vol. 29, no. 4, pp.294-295.
https://search.emarefa.net/detail/BIM-831830

Modern Language Association (MLA)

Ziadinov, Edem…[et al.]. Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery. Oman Medical Journal Vol. 29, no. 4 (2014), pp.294-295.
https://search.emarefa.net/detail/BIM-831830

American Medical Association (AMA)

Ziadinov, Edem& al-Sabti, Hilal& al-Tubi, Malik& Siddiqi, Muhammad Salman. Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery. Oman Medical Journal. 2014. Vol. 29, no. 4, pp.294-295.
https://search.emarefa.net/detail/BIM-831830

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-831830